Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 Study of Azilsartan Medoxomil + Chlorthalidone versus Telmisartan + Amlodipine in Stage 2 Hypertension
KCT0011297Phase 4Active, not recruiting
- Sponsor
- Celltrion Pharm
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azilsartan medoxomil, chlorthalidone, telmisartan, amlodipine in hypertension (HTN), sponsored by Celltrion Pharm. Started Jun 2022; status: active, not recruiting.
02
Drugs
azilsartan medoxomilchlorthalidonetelmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on KCT0011297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011297.